表紙:大腸癌診断検査の世界市場:医療機器のパイプライン評価
市場調査レポート
商品コード
366599

大腸癌診断検査の世界市場:医療機器のパイプライン評価

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 265 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.27円
大腸癌診断検査の世界市場:医療機器のパイプライン評価
出版日: 2020年11月30日
発行: GlobalData
ページ情報: 英文 265 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の大腸癌 (結腸直腸癌) 診断検査の関連製品の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 大腸癌診断検査の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 大腸癌診断検査の企業:治験段階別のパイプライン製品
  • 大腸癌診断検査:治験段階別のパイプライン製品

第5章 大腸癌診断検査市場:企業・製品の概要 (全119社分)

  • A2K Technologies
  • Abbott Diagnostics
  • Abcodia Ltd.
  • Acobiom
  • Advanced Marker Discovery, S.L.
  • Advpharma Inc.
  • Ambergen, Inc.
  • Ambrilia Biopharma Inc.
  • Arizona State University
  • ArtemixRx
  • Asuragen, Inc.
  • Bio Mark Ltd
  • Biocartis SA
  • Biodesix Inc.
  • BioMarCare Technologies Ltd.
  • BioMark Diagnostics Inc.
  • BioMarker Strategies, LLC
  • bioMerieux S.A.
  • Biomoda, Inc. (Inactive)
  • Biosceptre (Aust) Pty Ltd
  • BioSystems International
  • Biotechnostics GmbH
  • BioTime, Inc.
  • Biotron Limited
  • Castle Biosciences Incorporated
  • Cellmid Limited
  • Ceres Nanosciences, Inc.
  • Cernostics Inc.
  • China Sky One Medical, Inc.
  • Chronix Biomedical, Inc.
  • Cleveland Diagnostics Inc.
  • ColoPrev
  • Columbia University
  • Courtagen Life Sciences, Inc.
  • CS-Keys, Inc.
  • Di.V.A.L Toscana srl
  • Diadexus Inc
  • DiagnoCure Inc.
  • Diaxonhit S.A.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Eventus Diagnostics, Inc.
  • Exact Sciences Corporation
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fina Biotech
  • GenomicTree, Inc.
  • Ghent University
  • GlycoZym
  • Health Discovery Corporation
  • Human Metabolome Technologies, Inc.
  • Ikonisys, Inc.
  • InterGenetics Incorporated
  • IV Diagnostics, Inc.
  • John Hopkins University
  • Lab21 Limited
  • Laboratorios Alpha San Ignacio Pharma S.L.
  • Lightsphere Diagnostics
  • LX Diagnostics
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • Max-Delbruck-Centrum fur Molekulare Medizin (MDC)
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Merrimack Pharmaceuticals, Inc.
  • Metabiomics Corporation
  • Metabolomic Technologies Inc.
  • Metabolon, Inc.
  • MetaStat, Inc.
  • Milagen, Inc.
  • Miraculins Inc.
  • Mode Dx Ltd.
  • Moscow Institute of Physics and Technology
  • Myriad Genetics, Inc.
  • Nanosphere, Inc.
  • NetScientific Plc
  • Norda ASA
  • Novel Bio-spectrum Technologies, Inc.
  • Nuclea Biotechnologies Inc.
  • Nuvera Biosciences, Inc.
  • Oncimmune (USA) LLC
  • OncoVista Innovative Therapies, Inc.
  • On-Q-ity, Inc. (Inactive)
  • Origin Sciences Limited
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Cancer Biomarkers
  • Oxford Gene Technology Limited
  • Panacea Pharmaceuticals, Inc.
  • PleX Diagnostics
  • Precision Biologics, Inc.
  • Prediction Sciences
  • Protagen AG
  • Rabin Medical Center
  • Rosetta Genomics Ltd
  • Scienion AG
  • Seegene, Inc.
  • Shuwen Biotech Co. Ltd.
  • Siamab Therapeutics, Inc.
  • Skuldtech France
  • シスメックス
  • Tel Aviv University
  • The Chinese University of Hong Kong
  • The Walter and Eliza Hall Institute of Medical Research
  • TheraDiag SA
  • Theranostics Health, Inc.
  • Todos Medical Company Overview
  • Universal Diagnostics, S. L.
  • Universite De Lyon
  • University of Alabama at Birmingham
  • University of Illinois at Chicago
  • University of Texas at Austin
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vermillion, Inc.
  • Viomics Inc.
  • Vitatex Inc.
  • VolitionRX Ltd.
  • XEPTAGEN SpA

第6章 大腸癌診断検査市場市場:昨今の動向 (全99件)

第7章 付録

図表一覧

図表

List of Tables

List of Tables

  • Table 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Table 2: Colorectal Cancer - Pipeline Products by Territory
  • Table 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Table 4: Colorectal Cancer - Pipeline Produ

List of Figures

List of Figures

  • Figure 1: Colorectal Cancer - Pipeline Products by Stage of Development
  • Figure 2: Colorectal Cancer - Pipeline Products by Territory
  • Figure 3: Colorectal Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Colorectal Cancer - Pipeline
目次
Product Code: GDME1030EPD

GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Colorectal Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Colorectal Cancer Diagnostic Tests are used for detection of CRC based on the detection and measurement of cancer-specific biomarker/antibody/antigen present in patient's sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Colorectal Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Colorectal Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Colorectal Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Colorectal Cancer Overview

3 Products under Development

  • 3.1 Colorectal Cancer - Pipeline Products by Stage of Development
  • 3.2 Colorectal Cancer - Pipeline Products by Territory
  • 3.3 Colorectal Cancer - Pipeline Products by Regulatory Path
  • 3.4 Colorectal Cancer - Pipeline Products by Estimated Approval Date
  • 3.5 Colorectal Cancer - Ongoing Clinical Trials

4 Colorectal Cancer - Pipeline Products under Development by Companies

  • 4.1 Colorectal Cancer Companies - Pipeline Products by Stage of Development
  • 4.2 Colorectal Cancer - Pipeline Products by Stage of Development

5 Colorectal Cancer Companies and Product Overview

6 Colorectal Cancer- Recent Developments 1887 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer